BANK OF AMERICA CORP /DE/
BankPosition in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$71,970,626
-$27,241,070 QoQ
Shares Held
134,036
-29.3% QoQ
Ownership
0.580%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 39%
Shared 0%
None 61%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Mar 31, 2024CallValue
$53,408
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. MDGL ranks #32 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in MDGL
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,970,626 | 134,036 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $99,211,696 | 189,527 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $242,267,994 | 416,025 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $112,046,965 | 244,292 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $83,898,161 | 277,221 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $81,469,658 | 245,961 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $67,215,183 | 217,828 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $45,603,528 | 214,888 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $67,113,447 | 239,554 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $30,205,959 | 113,114 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $53,408 | 200 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $26,586,485 | 114,904 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $2,313,800 | 10,000 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $2,313,800 | 10,000 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $15,992,107 | 109,505 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,823,969 | 38,199 | Shares | Defined | 2023-08-14 | |
| 2023-06-30 | $6,930,000 | 30,000 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $8,339,100 | 36,100 | Put | Defined | 2023-08-14 | |
| 2023-03-31 | $12,917,784 | 53,322 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $26,934,909 | 92,799 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,622,993 | 40,360 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $742,140 | 10,368 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,354,270 | 44,377 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,253,590 | 38,395 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $377,964 | 4,737 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $478,379 | 4,911 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $691,875 | 5,915 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $585,086 | 5,263 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $846,780 | 7,132 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,567,034 | 31,497 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $405,966 | 6,081 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||